RWD Life Science Revenue and Competitors

Shenzhen, DE USA

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • RWD Life Science has 130 Employees.(i)
  • RWD Life Science grew their employee count by 23% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A13023%N/AN/A
#2
N/A4529%N/AN/A
Add Company

What Is RWD Life Science?

RWD Life Science specializes in Life Science, Animal Healthcare and Clinical Laboratory. Founded in 2002 and headquartered in Shenzhen, Our products and services have covered with more than 100 countries and regions. Dedicated to contributing our wisdom and effort to the improvement of the quality of life,we are also firmly committed to being the global advanced science enterprise.\n\nOriented by the customer demands and motivated by the excellent talents, RWD is continuously establishing long-term cooperation with domestic and foreign universities and investing into our R&D to achieve the innovation in our products, technologies, and service, to provide solutions with higher quality to our customers. \n\nBased on the Chinese market and serving customers around the world, RWD has not only achieved a strong reputation and advantage in the fields of respiratory anesthesia, neuroscience research, animal behavior research, surgery and nursing, and pathological analysis, but also gained the long-term trust and support from our domestic and foreign customers after our efforts during the past 20 years. \n\nLooking into the future, we shall adhere to the core values of quality, integrity, responsibility and contribute to the advancement and development of medical research and applications in international market. \n\nFor more information please contact us via rwd@rwdstco.com. Thanks!

keywords:N/A

N/A

Total Funding

130

Number of Employees

N/A

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.2M130-10%N/A
#2
$32.9M1314%N/A
#3
$55.2M13823%N/A
#4
$23.3M1467%N/A
#5
$39.6M1477%N/A